Cyrus PA - Search Results

1

Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease.

Cummings JL, Nadel A, Masterman D, Cyrus PA. Cummings JL, et al. Among authors: cyrus pa. J Geriatr Psychiatry Neurol. 2001 Summer;14(2):101-8. doi: 10.1177/089198870101400211. J Geriatr Psychiatry Neurol. 2001. PMID: 11419566 Clinical Trial.

2

Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.

Cummings JL, Cyrus PA, Bieber F, Mas J, Orazem J, Gulanski B. Cummings JL, et al. Among authors: cyrus pa. Neurology. 1998 May;50(5):1214-21. doi: 10.1212/wnl.50.5.1214. Neurology. 1998. PMID: 9595966 Clinical Trial.

3

Metrifonate treatment of AD: influence of APOE genotype.

Farlow MR, Cyrus PA, Nadel A, Lahiri DK, Brashear A, Gulanski B. Farlow MR, et al. Among authors: cyrus pa. Neurology. 1999 Dec 10;53(9):2010-6. doi: 10.1212/wnl.53.9.2010. Neurology. 1999. PMID: 10599773 Clinical Trial.

4

Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living.

Gélinas I, Gauthier S, Cyrus PA. Gélinas I, et al. Among authors: cyrus pa. J Geriatr Psychiatry Neurol. 2000 Spring;13(1):9-16. doi: 10.1177/089198870001300102. J Geriatr Psychiatry Neurol. 2000. PMID: 10753002 Clinical Trial.

5

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B. Morris JC, et al. Among authors: cyrus pa. Neurology. 1998 May;50(5):1222-30. doi: 10.1212/wnl.50.5.1222. Neurology. 1998. PMID: 9595967 Clinical Trial.

6

The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.

Raskind MA, Cyrus PA, Ruzicka BB, Gulanski BI. Raskind MA, et al. Among authors: cyrus pa. J Clin Psychiatry. 1999 May;60(5):318-25. doi: 10.4088/jcp.v60n0510. J Clin Psychiatry. 1999. PMID: 10362441 Clinical Trial.

7

Metrifonate therapy in Alzheimer's disease: a pooled analysis of four randomized, double-blind, placebo-controlled trials.

Farlow MR, Cyrus PA. Farlow MR, et al. Among authors: cyrus pa. Dement Geriatr Cogn Disord. 2000 Jul-Aug;11(4):202-11. doi: 10.1159/000017238. Dement Geriatr Cogn Disord. 2000. PMID: 10867446

8

Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose study.

Cutler NR, Jhee SS, Cyrus P, Bieber F, TanPiengco P, Sramek JJ, Gulanski B. Cutler NR, et al. Life Sci. 1998;62(16):1433-41. doi: 10.1016/s0024-3205(98)00082-4. Life Sci. 1998. PMID: 9585171 Clinical Trial.

9

Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: a randomized, double-masked, placebo-controlled trial. Metrifonate Study Group.

Jann MW, Cyrus PA, Eisner LS, Margolin DI, Griffin T, Gulanski B. Jann MW, et al. Among authors: cyrus pa. Clin Ther. 1999 Jan;21(1):88-102. doi: 10.1016/s0149-2918(00)88270-3. Clin Ther. 1999. PMID: 10090427 Clinical Trial.

10

Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate Study Group.

Blass JP, Cyrus PA, Bieber F, Gulanski B. Blass JP, et al. Among authors: cyrus pa. Alzheimer Dis Assoc Disord. 2000 Jan-Mar;14(1):39-45. doi: 10.1097/00002093-200001000-00005. Alzheimer Dis Assoc Disord. 2000. PMID: 10718203 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters